1 Carbetocin (Duratocin) Market Overview 1.1 Product Overview and Scope of Carbetocin (Duratocin) 1.2 Carbetocin (Duratocin) Segment by Type 1.2.1 Global Carbetocin (Duratocin) Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Tablets 1.2.3 Injection 1.3 Carbetocin (Duratocin) Segment by Application 1.3.1 Carbetocin (Duratocin) Sales Comparison by Application: (2021-2027) 1.3.2 Oxytocic 1.3.3 Antihemorrhagic 1.3.4 Uterotonic 1.4 Global Carbetocin (Duratocin) Market Size Estimates and Forecasts 1.4.1 Global Carbetocin (Duratocin) Revenue 2016-2027 1.4.2 Global Carbetocin (Duratocin) Sales 2016-2027 1.4.3 Carbetocin (Duratocin) Market Size by Region: 2016 Versus 2021 Versus 2027 2 Carbetocin (Duratocin) Market Competition by Manufacturers 2.1 Global Carbetocin (Duratocin) Sales Market Share by Manufacturers (2016-2021) 2.2 Global Carbetocin (Duratocin) Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Carbetocin (Duratocin) Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Carbetocin (Duratocin) Manufacturing Sites, Area Served, Product Type 2.5 Carbetocin (Duratocin) Market Competitive Situation and Trends 2.5.1 Carbetocin (Duratocin) Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Carbetocin (Duratocin) Players Market Share by Revenue 2.5.3 Global Carbetocin (Duratocin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Carbetocin (Duratocin) Retrospective Market Scenario by Region 3.1 Global Carbetocin (Duratocin) Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Carbetocin (Duratocin) Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Carbetocin (Duratocin) Market Facts & Figures by Country 3.3.1 North America Carbetocin (Duratocin) Sales by Country 3.3.2 North America Carbetocin (Duratocin) Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Carbetocin (Duratocin) Market Facts & Figures by Country 3.4.1 Europe Carbetocin (Duratocin) Sales by Country 3.4.2 Europe Carbetocin (Duratocin) Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Carbetocin (Duratocin) Market Facts & Figures by Region 3.5.1 Asia Pacific Carbetocin (Duratocin) Sales by Region 3.5.2 Asia Pacific Carbetocin (Duratocin) Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Carbetocin (Duratocin) Market Facts & Figures by Country 3.6.1 Latin America Carbetocin (Duratocin) Sales by Country 3.6.2 Latin America Carbetocin (Duratocin) Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Carbetocin (Duratocin) Market Facts & Figures by Country 3.7.1 Middle East and Africa Carbetocin (Duratocin) Sales by Country 3.7.2 Middle East and Africa Carbetocin (Duratocin) Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Carbetocin (Duratocin) Historic Market Analysis by Type 4.1 Global Carbetocin (Duratocin) Sales Market Share by Type (2016-2021) 4.2 Global Carbetocin (Duratocin) Revenue Market Share by Type (2016-2021) 4.3 Global Carbetocin (Duratocin) Price by Type (2016-2021) 5 Global Carbetocin (Duratocin) Historic Market Analysis by Application 5.1 Global Carbetocin (Duratocin) Sales Market Share by Application (2016-2021) 5.2 Global Carbetocin (Duratocin) Revenue Market Share by Application (2016-2021) 5.3 Global Carbetocin (Duratocin) Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Beacon Pharmaceuticals Limited 6.1.1 Beacon Pharmaceuticals Limited Corporation Information 6.1.2 Beacon Pharmaceuticals Limited Description and Business Overview 6.1.3 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Beacon Pharmaceuticals Limited Product Portfolio 6.1.5 Beacon Pharmaceuticals Limited Recent Developments/Updates 6.2 Ferring Inc. 6.2.1 Ferring Inc. Corporation Information 6.2.2 Ferring Inc. Description and Business Overview 6.2.3 Ferring Inc. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Ferring Inc. Product Portfolio 6.2.5 Ferring Inc. Recent Developments/Updates 6.3 Polypeptide Laboraries France 6.3.1 Polypeptide Laboraries France Corporation Information 6.3.2 Polypeptide Laboraries France Description and Business Overview 6.3.3 Polypeptide Laboraries France Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Polypeptide Laboraries France Product Portfolio 6.3.5 Polypeptide Laboraries France Recent Developments/Updates 6.4 Chemos GmbH & Co. KG 6.4.1 Chemos GmbH & Co. KG Corporation Information 6.4.2 Chemos GmbH & Co. KG Description and Business Overview 6.4.3 Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Chemos GmbH & Co. KG Product Portfolio 6.4.5 Chemos GmbH & Co. KG Recent Developments/Updates 6.5 Hangzhou Dayangchem Co. Ltd. 6.5.1 Hangzhou Dayangchem Co. Ltd. Corporation Information 6.5.2 Hangzhou Dayangchem Co. Ltd. Description and Business Overview 6.5.3 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Hangzhou Dayangchem Co. Ltd. Product Portfolio 6.5.5 Hangzhou Dayangchem Co. Ltd. Recent Developments/Updates 6.6 Acinopeptide Co., Ltd. 6.6.1 Acinopeptide Co., Ltd. Corporation Information 6.6.2 Acinopeptide Co., Ltd. Description and Business Overview 6.6.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Acinopeptide Co., Ltd. Product Portfolio 6.6.5 Acinopeptide Co., Ltd. Recent Developments/Updates 6.7 Bachem AG 6.6.1 Bachem AG Corporation Information 6.6.2 Bachem AG Description and Business Overview 6.6.3 Bachem AG Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Bachem AG Product Portfolio 6.7.5 Bachem AG Recent Developments/Updates 6.8 Clearsynth Canada INC. 6.8.1 Clearsynth Canada INC. Corporation Information 6.8.2 Clearsynth Canada INC. Description and Business Overview 6.8.3 Clearsynth Canada INC. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Clearsynth Canada INC. Product Portfolio 6.8.5 Clearsynth Canada INC. Recent Developments/Updates 6.9 Leap Labchem Co., Ltd 6.9.1 Leap Labchem Co., Ltd Corporation Information 6.9.2 Leap Labchem Co., Ltd Description and Business Overview 6.9.3 Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Leap Labchem Co., Ltd Product Portfolio 6.9.5 Leap Labchem Co., Ltd Recent Developments/Updates 6.10 Chemieliva Pharmaceutical Co., Ltd. 6.10.1 Chemieliva Pharmaceutical Co., Ltd. Corporation Information 6.10.2 Chemieliva Pharmaceutical Co., Ltd. Description and Business Overview 6.10.3 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Chemieliva Pharmaceutical Co., Ltd. Product Portfolio 6.10.5 Chemieliva Pharmaceutical Co., Ltd. Recent Developments/Updates 6.11 Acinopeptide Co., Ltd. 6.11.1 Acinopeptide Co., Ltd. Corporation Information 6.11.2 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Description and Business Overview 6.11.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Acinopeptide Co., Ltd. Product Portfolio 6.11.5 Acinopeptide Co., Ltd. Recent Developments/Updates 6.12 BOC Sciences 6.12.1 BOC Sciences Corporation Information 6.12.2 BOC Sciences Carbetocin (Duratocin) Description and Business Overview 6.12.3 BOC Sciences Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2016-2021) 6.12.4 BOC Sciences Product Portfolio 6.12.5 BOC Sciences Recent Developments/Updates 7 Carbetocin (Duratocin) Manufacturing Cost Analysis 7.1 Carbetocin (Duratocin) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Carbetocin (Duratocin) 7.4 Carbetocin (Duratocin) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Carbetocin (Duratocin) Distributors List 8.3 Carbetocin (Duratocin) Customers 9 Carbetocin (Duratocin) Market Dynamics 9.1 Carbetocin (Duratocin) Industry Trends 9.2 Carbetocin (Duratocin) Growth Drivers 9.3 Carbetocin (Duratocin) Market Challenges 9.4 Carbetocin (Duratocin) Market Restraints 10 Global Market Forecast 10.1 Carbetocin (Duratocin) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Carbetocin (Duratocin) by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Carbetocin (Duratocin) by Type (2022-2027) 10.2 Carbetocin (Duratocin) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Carbetocin (Duratocin) by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Carbetocin (Duratocin) by Application (2022-2027) 10.3 Carbetocin (Duratocin) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Carbetocin (Duratocin) by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Carbetocin (Duratocin) by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Carbetocin (Duratocin) Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Carbetocin (Duratocin) Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Carbetocin (Duratocin) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Carbetocin (Duratocin) Covered in This Study Table 5. Global Carbetocin (Duratocin) Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Carbetocin (Duratocin) Sales Share by Manufacturers (2016-2021) Table 7. Global Carbetocin (Duratocin) Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Carbetocin (Duratocin) Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Carbetocin (Duratocin) Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Carbetocin (Duratocin) Manufacturing Sites and Area Served Table 11. Manufacturers Carbetocin (Duratocin) Product Type Table 12. Global Carbetocin (Duratocin) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Carbetocin (Duratocin) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carbetocin (Duratocin) as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Carbetocin (Duratocin) Sales by Region (2016-2021) & (K Units) Table 16. Global Carbetocin (Duratocin) Sales Market Share by Region (2016-2021) Table 17. Global Carbetocin (Duratocin) Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Carbetocin (Duratocin) Sales by Country (2016-2021) & (K Units) Table 19. North America Carbetocin (Duratocin) Sales Market Share by Country (2016-2021) Table 20. North America Carbetocin (Duratocin) Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Carbetocin (Duratocin) Revenue Market Share by Country (2016-2021) Table 22. Europe Carbetocin (Duratocin) Sales by Country (2016-2021) & (K Units) Table 23. Europe Carbetocin (Duratocin) Sales Market Share by Country (2016-2021) Table 24. Europe Carbetocin (Duratocin) Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Carbetocin (Duratocin) Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Carbetocin (Duratocin) Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Carbetocin (Duratocin) Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Carbetocin (Duratocin) Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Carbetocin (Duratocin) Revenue Market Share by Region (2016-2021) Table 30. Latin America Carbetocin (Duratocin) Sales by Country (2016-2021) & (K Units) Table 31. Latin America Carbetocin (Duratocin) Sales Market Share by Country (2016-2021) Table 32. Latin America Carbetocin (Duratocin) Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Carbetocin (Duratocin) Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Carbetocin (Duratocin) Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Carbetocin (Duratocin) Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Carbetocin (Duratocin) Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Carbetocin (Duratocin) Revenue Market Share by Country (2016-2021) Table 38. Global Carbetocin (Duratocin) Sales (K Units) by Type (2016-2021) Table 39. Global Carbetocin (Duratocin) Sales Market Share by Type (2016-2021) Table 40. Global Carbetocin (Duratocin) Revenue (Million US$) by Type (2016-2021) Table 41. Global Carbetocin (Duratocin) Revenue Share by Type (2016-2021) Table 42. Global Carbetocin (Duratocin) Price (USD/Unit) by Type (2016-2021) Table 43. Global Carbetocin (Duratocin) Sales (K Units) by Application (2016-2021) Table 44. Global Carbetocin (Duratocin) Sales Market Share by Application (2016-2021) Table 45. Global Carbetocin (Duratocin) Revenue (Million US$) by Application (2016-2021) Table 46. Global Carbetocin (Duratocin) Revenue Share by Application (2016-2021) Table 47. Global Carbetocin (Duratocin) Price (USD/Unit) by Application (2016-2021) Table 48. Beacon Pharmaceuticals Limited Corporation Information Table 49. Beacon Pharmaceuticals Limited Description and Business Overview Table 50. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Product Table 52. Beacon Pharmaceuticals Limited Recent Developments/Updates Table 53. Ferring Inc. Corporation Information Table 54. Ferring Inc. Description and Business Overview Table 55. Ferring Inc. Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Ferring Inc. Carbetocin (Duratocin) Product Table 57. Ferring Inc. Recent Developments/Updates Table 58. Polypeptide Laboraries France Corporation Information Table 59. Polypeptide Laboraries France Description and Business Overview Table 60. Polypeptide Laboraries France Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Polypeptide Laboraries France Carbetocin (Duratocin) Product Table 62. Polypeptide Laboraries France Recent Developments/Updates Table 63. Chemos GmbH & Co. KG Corporation Information Table 64. Chemos GmbH & Co. KG Description and Business Overview Table 65. Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Chemos GmbH & Co. KG Carbetocin (Duratocin) Product Table 67. Chemos GmbH & Co. KG Recent Developments/Updates Table 68. Hangzhou Dayangchem Co. Ltd. Corporation Information Table 69. Hangzhou Dayangchem Co. Ltd. Description and Business Overview Table 70. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Product Table 72. Hangzhou Dayangchem Co. Ltd. Recent Developments/Updates Table 73. Acinopeptide Co., Ltd. Corporation Information Table 74. Acinopeptide Co., Ltd. Description and Business Overview Table 75. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Table 77. Acinopeptide Co., Ltd. Recent Developments/Updates Table 78. Bachem AG Corporation Information Table 79. Bachem AG Description and Business Overview Table 80. Bachem AG Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Bachem AG Carbetocin (Duratocin) Product Table 82. Bachem AG Recent Developments/Updates Table 83. Clearsynth Canada INC. Corporation Information Table 84. Clearsynth Canada INC. Description and Business Overview Table 85. Clearsynth Canada INC. Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Clearsynth Canada INC. Carbetocin (Duratocin) Product Table 87. Clearsynth Canada INC. Recent Developments/Updates Table 88. Leap Labchem Co., Ltd Corporation Information Table 89. Leap Labchem Co., Ltd Description and Business Overview Table 90. Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Leap Labchem Co., Ltd Carbetocin (Duratocin) Product Table 92. Leap Labchem Co., Ltd Recent Developments/Updates Table 93. Chemieliva Pharmaceutical Co., Ltd. Corporation Information Table 94. Chemieliva Pharmaceutical Co., Ltd. Description and Business Overview Table 95. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Product Table 97. Chemieliva Pharmaceutical Co., Ltd. Recent Developments/Updates Table 98. Acinopeptide Co., Ltd. Corporation Information Table 99. Acinopeptide Co., Ltd. Description and Business Overview Table 100. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 101. Acinopeptide Co., Ltd. Carbetocin (Duratocin) Product Table 102. Acinopeptide Co., Ltd. Recent Developments/Updates Table 103. BOC Sciences Corporation Information Table 104. BOC Sciences Description and Business Overview Table 105. BOC Sciences Carbetocin (Duratocin) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 106. BOC Sciences Carbetocin (Duratocin) Product Table 107. BOC Sciences Recent Developments/Updates Table 108. Production Base and Market Concentration Rate of Raw Material Table 109. Key Suppliers of Raw Materials Table 110. Carbetocin (Duratocin) Distributors List Table 111. Carbetocin (Duratocin) Customers List Table 112. Carbetocin (Duratocin) Market Trends Table 113. Carbetocin (Duratocin) Growth Drivers Table 114. Carbetocin (Duratocin) Market Restraints Table 115. Global Carbetocin (Duratocin) Sales Forecast by Type (2022-2027) & (K Units) Table 116. Global Carbetocin (Duratocin) Sales Market Share Forecast by Type (2022-2027) Table 117. Global Carbetocin (Duratocin) Revenue Forecast by Type (2022-2027) & (US$ Million) Table 118. Global Carbetocin (Duratocin) Revenue Market Share Forecast by Type (2022-2027) Table 119. Global Carbetocin (Duratocin) Sales Forecast by Application (2022-2027) & (K Units) Table 120. Global Carbetocin (Duratocin) Sales Market Share Forecast by Application (2022-2027) Table 121. Global Carbetocin (Duratocin) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 122. Global Carbetocin (Duratocin) Revenue Market Share Forecast by Application (2022-2027) Table 123. Global Carbetocin (Duratocin) Sales Forecast by Region (2022-2027) & (K Units) Table 124. Global Carbetocin (Duratocin) Sales Market Share Forecast by Region (2022-2027) Table 125. Global Carbetocin (Duratocin) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 126. Global Carbetocin (Duratocin) Revenue Market Share Forecast by Region (2022-2027) Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Carbetocin (Duratocin) Figure 2. Global Carbetocin (Duratocin) Market Share by Type in 2020 & 2027 Figure 3. Tablets Product Picture Figure 4. Injection Product Picture Figure 5. Global Carbetocin (Duratocin) Market Share by Application in 2020 & 2027 Figure 6. Oxytocic Figure 7. Antihemorrhagic Figure 8. Uterotonic Figure 9. Global Carbetocin (Duratocin) Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Carbetocin (Duratocin) Market Size 2016-2027 (US$ Million) Figure 11. Global Carbetocin (Duratocin) Sales 2016-2027 (K Units) Figure 12. Global Carbetocin (Duratocin) Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Carbetocin (Duratocin) Sales Share by Manufacturers in 2020 Figure 14. Global Carbetocin (Duratocin) Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Carbetocin (Duratocin) Players: Market Share by Revenue in 2020 Figure 16. Carbetocin (Duratocin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Carbetocin (Duratocin) Sales Market Share by Region (2016-2021) Figure 18. Global Carbetocin (Duratocin) Sales Market Share by Region in 2020 Figure 19. Global Carbetocin (Duratocin) Revenue Market Share by Region (2016-2021) Figure 20. Global Carbetocin (Duratocin) Revenue Market Share by Region in 2020 Figure 21. U.S. Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Carbetocin (Duratocin) Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Carbetocin (Duratocin) by Type (2016-2021) Figure 46. Sales Market Share of Carbetocin (Duratocin) by Application (2016-2021) Figure 47. Sales Market Share of Carbetocin (Duratocin) by Application in 2020 Figure 48. Revenue Share of Carbetocin (Duratocin) by Application (2016-2021) Figure 49. Revenue Share of Carbetocin (Duratocin) by Application in 2020 Figure 50. Manufacturing Cost Structure of Carbetocin (Duratocin) Figure 51. Manufacturing Process Analysis of Carbetocin (Duratocin) Figure 52. Carbetocin (Duratocin) Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Beacon Pharmaceuticals Limited Ferring Inc. Polypeptide Laboraries France Chemos GmbH & Co. KG Hangzhou Dayangchem Co. Ltd. Acinopeptide Co., Ltd. Bachem AG Clearsynth Canada INC. Leap Labchem Co., Ltd Chemieliva Pharmaceutical Co., Ltd. Acinopeptide Co., Ltd. BOC Sciences